CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus
Conditions: Cerebrospinal Fluid Levels of Amyloid Beta 1-42, H-tau and Phospho-tau Proteins; Cognitive Impairment and Its Evolution After Hydrocephalus Treatment; Motor Impairment and Its Evolution After Hydrocephalus Treatment; Ventricular Size and Its Evolution After Implantation of a Ventriculop eritoneal Shunt Intervention: Diagnostic Test: Lumbar CSF protein marker determination Sponsor: University of Valencia Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials